bioRxivBioinformaticsPreprint
Exploration of Chemical Space with Partial Labeled Noisy Student Self-Training for Improving Deep Learning: Application to Drug Metabolism
Abstract
MotivationDrug discovery is time-consuming and costly. Machine learning, especially deep learning, shows a great potential in accelerating the drug discovery process and reducing its cost. A big challenge in developing robust and generalizable deep learning models for drug design is the lack of a large amount of data with high quality and balanced labels. To address this challenge, we developed a self-training method PLANS that exploits millions of unlabeled chemical compounds as well as partially labeled pharmacological data to improve the performance of neural network models. ResultWe evaluated the self-training with PLANS for Cytochrome P450 binding activity prediction task, and proved that our method could significantly improve the performance of the neural network model with a large margin. Compared with the baseline deep neural network model, the PLANS-trained neural network model improved accuracy, precision, recall, and F1 score by 13.4%, 12.5%, 8.3%, and 10.3%, respectively. The self-training with PLANS is model agnostic, and can be applied to any deep learning architectures. Thus, PLANS provides a general solution to utilize unlabeled and partially labeled data to improve the predictive modeling for drug discovery. AvailabilityThe code that implements PLANS is available at https://github.com/XieResearchGroup/PLANS
- research focus: drug response / drug discovery
- research focus: benchmarking
- approach: deep learning
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Deep Batch Active Learning for Drug Discovery
Michael Bailey, Saeed Moayedpour, … Sven Jäger·bioRxiv·Jul 26, 2023
- Conversational Chemistry: A Novel Approach to Chemical Search and Property Prediction
JJ Ben-Joseph, Tim Oates·bioRxiv·Nov 11, 2023
- DeepSide: A Deep Learning Framework for Drug Side Effect Prediction
Onur Can Üner, Ramazan Gökberk Cinbiş, … A. Ercüment Çiçek·bioRxiv·Nov 18, 2019
- Expanding Chemical Space: Developing a Compound Generative Pre-trained Transformer for De Novo Drug Design
Tze Shin Chen, Jhih‐Wei Chu, Jinn‐Moon Yang·bioRxiv·Jan 24, 2025
- Deep learning models for chemical perturbation prediction do not yet utilise drug molecular features
Jinming Bai, Sharon Prince, Geoff Nitschke·bioRxiv·May 15, 2026
- Deep Learning for Virtual Screening: Five Reasons to Use ROC Cost Functions
V. Golkov, A. Becker, … D. Cremers·bioRxiv·Jun 25, 2020